Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protein kinase C beta II mRNA levels decrease in the striatum and cortex of transgenic Huntington's disease mice.

A S Harris1, E M Denovan-Wright, L C Hamilton

  • 1Laboratory of Molecular Neurobiology, Department of Pharmacology, Dalhousie University, Halifax NS B3H 4H7.

Journal of Psychiatry & Neuroscience : JPN
|April 9, 2001
PubMed
Summary

Huntington's disease (HD) involves an expanded CAG repeat in the huntingtin gene. This study found decreased protein kinase C beta II (PKC beta II) mRNA in symptomatic HD mice, suggesting a role for PKC beta II in HD's molecular pathology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early alterations of functional connectivity, regional brain volumes and astrocyte markers in the beta-sitosterol beta-d-glucoside (BSSG) rat model of parkinsonism.

Experimental neurology·2024
Same author

A new experimental model for the investigation of sequential hermaphroditism.

Scientific reports·2021
Same author

Use of pre-operative calcium and vitamin D supplementation to prevent post-operative hypocalcaemia in patients undergoing thyroidectomy: a systematic review.

The Journal of laryngology and otology·2021
Same author

Do patients benefit from physiotherapy for shoulder dysfunction following neck dissection? A systematic review.

The Journal of laryngology and otology·2020
Same author

Ten years of deep neck space abscesses.

The Journal of laryngology and otology·2019
Same author

Hypocalcaemia following laryngectomy: prevalence and risk factors.

The Journal of laryngology and otology·2018

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Huntington's disease (HD) is a neurodegenerative disorder caused by expanded CAG repeats in the huntingtin gene.
  • The precise function of the huntingtin protein, both normal and mutant, is not fully understood.
  • Altered gene expression is a hallmark of HD, impacting various brain regions.

Purpose of the Study:

  • To identify differences in steady-state mRNA levels between wild-type and a transgenic mouse model of HD.
  • To investigate the role of specific gene expression changes in the pathophysiology of Huntington's disease.

Main Methods:

  • Differential display was employed to compare mRNA profiles.
  • Analysis focused on the R6/2 transgenic mouse model exhibiting HD-like symptoms.

Related Experiment Videos

  • Quantitative assessment of mRNA levels in striatum and cortex.

    • Main Results:

    • Steady-state mRNA levels of protein kinase C beta II (PKC beta II) subunit were significantly decreased in symptomatic R6/2 mice compared to wild-type controls.
    • This reduction in PKC beta II mRNA was observed in both the striatum and cortex.
    • Findings align with previous observations of decreased PKC beta II immunoreactivity in human HD patients.

    Conclusions:

    • The study identifies a significant downregulation of PKC beta II mRNA in a mouse model of Huntington's disease.
    • Reduced PKC beta II may contribute to the cognitive and synaptic deficits observed in HD, potentially affecting brain plasticity and learning.
    • These findings highlight the impact of huntingtin gene expression on broader transcriptional changes in the brain, even in non-neurodegenerative regions.